Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Biotech components
Biotech components
Bacteria
Products 41 to 50 of 53
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
Methane Bioconversion: Isobutanol
by
Intrexon
Biotech components:
Bacteria
+
Gene Editing
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/13 11:47 (5 years ago)
Date last modified:
2019/09/16 16:29 (5 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Energy
+
Industrial
Market status:
Early Stage Concept
Organization type(s):
Public Company
Product categories:
Fuel and Energy
+
Chemical
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
Methane bioconversion: Isobutyraldehyde
by
Intrexon
Biotech components:
Bacteria
+
Gene Editing
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/13 11:47 (5 years ago)
Date last modified:
2019/09/13 11:47 (5 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Energy
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Fuel and Energy
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Input
Methane bioconversion: isoprene
by
Intrexon
Biotech components:
Bacteria
+
Gene Editing
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/13 11:47 (5 years ago)
Date last modified:
2019/09/13 11:47 (5 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
Early Stage Concept
Organization type(s):
Public Company
Product categories:
Chemical
+
Other (Industrial)
Production process:
N/A
Source:
N/A
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Input
Organic LED Coatings
by
ENABLE
Biotech components:
Bacteria
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/12/18 14:35 (3 years ago)
Date last modified:
2020/12/18 14:35 (3 years ago)
Known funding amount:
2,687,657 EUR
Funding types:
Government
Industry:
Industrial
Market status:
Under Development
Organization type(s):
Research Institution
Product categories:
Other
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Input
+
Platform
Personalized Probiotics
by
Thryve
Biotech components:
Bacteria
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/10/08 14:52 (6 years ago)
Known funding amount:
1,900,000 USD
Funding types:
Venture Capital
Industry:
Health
Market status:
On the market
Organization type(s):
Private Company
Product categories:
Personal Care (Ingested)
Production process:
Closed Production
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
Phyzyme XP Phytase
by
DuPont
+
Danisco
Biotech components:
Bacteria
Business models:
B2B
Country of production:
USA
+
Denmark
Country of distribution:
UK
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Feed
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
DWDP
(NYSE)
Value chain stage:
Input
Polyhydroxyalkanoate (PHA) Bioplastics
by
Genecis
Biotech components:
Bacteria
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/12/18 14:34 (3 years ago)
Date last modified:
2020/12/18 14:34 (3 years ago)
Known funding amount:
3,200,000
Funding types:
Foundation
+
Private Funding
Industry:
Industrial
+
Multipurpose
+
Novelty
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Construction
+
Design
+
Other
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Input
+
Platform
Solein
by
Solar Foods
Biotech components:
Bacteria
Business models:
B2B
+
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/12/18 14:34 (3 years ago)
Date last modified:
2020/12/18 14:34 (3 years ago)
Known funding amount:
18,500,000
Funding types:
Private Funding
Industry:
Food & Agriculture
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Feed
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Input
+
Platform
SOS-Chromotest
by
Environmental Bio-Detection Products, Inc.
Biotech components:
Bacteria
Business models:
B2B
Country of production:
Canada
Country of distribution:
Canada
Intended consumer:
Commercial
+
Government
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
N/A
Funding types:
Private Funding
Industry:
Science
Market status:
On the market
Organization type(s):
Private Company
Product categories:
Research
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
N/A
Value chain stage:
Finished Product
Vaxonella
by
Prokarium
Biotech components:
Bacteria
Business models:
B2C
Country of production:
UK
Country of distribution:
N/A
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2019/05/15 16:12 (5 years ago)
Known funding amount:
12,600,000 USD
Funding types:
Venture Capital
Industry:
Health
Market status:
On the market
+
Under Development
Organization type(s):
Private Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Finished Product
1
2
3
4
5
6
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
